Home Table of Contents

§ 25705. Specific Regulatory Levels Posing No Significant Risk.

27 CA ADC § 25705BARCLAYS OFFICIAL CALIFORNIA CODE OF REGULATIONS

Barclays Official California Code of Regulations Currentness
Title 27. Environmental Protection
Division 4. Office of Environmental Health Hazard Assessment
Chapter 1. Safe Drinking Water and Toxic Enforcement Act of 1986
Article 7. NO Significant Risk Levels
27 CCR § 25705
§ 25705. Specific Regulatory Levels Posing No Significant Risk.
(a) Daily exposure to a chemical at a level which does not exceed the level set forth in subsections (b), (c) and (d) for such chemical shall be deemed to pose no significant risk within the meaning of Section 25249.10(c) of the Act.
(b) Levels of exposure deemed to pose no significant risk may be determined by the lead agency based on a risk assessment conducted by the lead agency pursuant to the guidelines set forth in Section 25703, or a risk assessment reviewed by the lead agency and determined to be consistent with the guidelines set forth in Section 25703.
(1) The following levels based on risk assessments conducted or reviewed by the lead agency shall be deemed to pose no significant risk:
Chemical Name
Level (micrograms/day)
Acrylonitrile
0.7
Aldrin
0.04
Arsenic
0.06 (inhalation)
Asbestos
100 fibers inhaled/day*
Benz[a]anthracene
0.033 (oral)
Benzene
6.4 (oral)
13 (inhalation)
Benzidine
0.001
Benzo[b]fluoranthene
0.096 (oral)
Benzo[j]fluoranthene
0.11 (oral)
Benzofuran
1.1
Bis(2-chloroethyl)ether
0.3
Bis(chloromethyl)ether
0.02
Bromochloroacetic acid
0.70
Bromodichloroacetic acid
0.95
Bromoethane
96
Bromoform
64
Butylated hydroxyanisole
4000
Cadmium
0.05 (inhalation)
Carbon tetrachloride
5
N-Carboxymethyl-N-nitrosourea
0.70
p-Chloroaniline
1.5
p-Chloroaniline hydrochloride
1.9
Chloroethane
150
Chlorothalonil
41
Chromium (hexavalent compounds)
0.001 (inhalation)
Chrysene
0.35 (oral)
C.I. Direct Blue 218
50
DDT, DDE and DDD (in combination)
2
7H-Dibenzo[c,g]carbazole
0.0030 (oral)
Dibenzo[a,h]pyrene
0.0054 (oral)
Dibenzo[a,i]pyrene
0.0050 (oral)
1,2-Dibromo-3-chloropropane (DBCP)
0.1
para-Dichlorobenzene
20
3,3'-Dichlorobenzidine
0.6
Dichloromethane (Methylene chloride)
200 (inhalation)
1,2-Dichloropropane
9.7
Dieldrin
0.04
Di(2-ethylhexyl)phthalate (DEHP)
310
Diisononyl phthalate (DINP)
146
3,3'-Dimethoxybenzidine
0.15
3,3'-Dimethoxybenzidine dihydrochloride
0.19
3,3'-Dimethylbenzidine
0.044
3,3'-Dimethlybenzidine dihydrochloride
0.059
1,4-Dioxane
30
Epichlorohydrin
9
Ethylbenzene
54 (inhalation)
41 (oral)
Ethylene dibromide
0.2 (ingestion)
3 (inhalation)
Ethylene dichloride
10
Ethylene oxide
2
Glycidol
0.54
Glyphosate
1100
Hexachlorobenzene
0.4
Hexachlorodibenzodioxin
0.0002
Hexachlorocyclohexane (technical grade)
0.2
Lead
15 (oral)
Lead acetate
23 (oral)
Lead phosphate
58 (oral)
Lead subacetate
41 (oral)
Malathion
180
2-Methylaziridine (propyleneimine)
0.028
5-Methylchrysene
0.0084 (oral)
Methylhydrazine
0.058 (oral)
0.090 (inhalation)
Methylhydrazine sulfate
0.18
4-Methylimidazole
29
5-Morpholinomethyl-3-[(5-nitrofurfurylidene)
0.18
-amino]-2-oxazolidinone
MX (3-chloro-4-(dichloromethyl)-5-hydroxy-2
0.11
(5H)-furanone)
Naphthalene
5.8
Nitromethane
39
N-Nitroso-n-dibutylamine
0.06
N-Nitrosodiethylamine
0.02
N-Nitrosodimethylamine
0.04
N-Nitrosodiphenylamine
80
N-Nitrosodi-n-propylamine
0.1
N-Nitroso-N-ethylurea
0.03
N-Nitroso-N-methylurea
0.006
Phenyl glycidyl ether
5.0
Phenylhydrazine
1.0
Phenylhydrazine hydrochloride
1.4
Polybrominated biphenyls
0.02
Polygeenan
1200
Styrene
27
2,3,7,8-Tetrachlorodibenzo-p-dioxin
0.000005
Tetranitromethane
0.059
Toxaphene
0.6
Trichloroethylene
14 (oral)
50 (inhalation)
2,4,6-Trichlorophenol
10
2,4,6-Trinitrotoluene
8.2
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP)
5.4
Urethane
0.7
Vinyl chloride
3
Vinylidene chloride
0.88
2,6-Xylidine
110
__________
*Fibers equal to or greater than 5 micrometers in length and 0.3 micrometers in width, with a length to width ratio of greater than or equal to 3:1 as measured by phase contrast microscopy.
(c) Unless a specific regulatory level for a chemical known to the state to cause cancer has been established in subsection (b), levels of exposure deemed to pose no significant risk may be determined by the lead agency based on state or federal risk assessments.
(1) Any interested party may request the lead agency to reevaluate a level established in this subsection based on scientific considerations that indicate the need for the lead agency to develop its own risk assessment or to conduct a detailed review of the risk assessment used to derive the level in question. Such request shall be made in writing, and shall include a description of the scientific considerations that indicate the need for the lead agency to develop its own risk assessment or to conduct a detailed review of the risk assessment used to derive the level in question. The lead agency may establish a level for the chemical in question in subsection (b) as it deems necessary.
(2) The following levels based on state or federal risk assessments shall be deemed to pose no significant risk:
Chemical Name
Level (micrograms/day)
Acetaldehyde
90 (inhalation)
Acrylamide
0.2
Aniline
100
Azobenzene
6
Benzo[a]pyrene
0.06
Benzyl chloride
4
Beryllium oxide
0.1
Beryllium sulfate
0.0002
Bromodichloromethane
5
1,3-Butadiene
0.4
Chlordane
0.5
Chloroform
20 (ingestion)
40 (inhalation)
Coke oven emissions
0.3
DDVP (Dichlorvos)
2
Dichloromethane (Methylene chloride)
50
2,4-Dinitrotoluene
2
Folpet
200
Formaldehyde (gas)
40
Furmecyclox
20
Heptachlor
0.2
Heptachlor epoxide
0.08
Hexachlorocyclohexane
alpha isomer
0.3
beta isomer
0.5
gamma isomer
0.6
Hydrazine
0.04
Hydrazine sulfate
0.2
Imazalil
11
4,4' -Methylene
bis (N,N-dimethyl) benzeneamine
20
Nickel refinery dust
0.8
Nickel subsulfide
0.4
N-Nitrosodiethanolamine
0.3
N-Nitrosomethylethylamine
0.03
N-Nitrosopyrrolidine
0.3
Pentachlorophenol
40
Polychlorinated biphenyls (PCBs)
0.09
Tetrachloroethylene
14
(d) Unless a specific regulatory level has been established for a chemical known to the state to cause cancer in subsection (b) or (c), levels of exposure deemed to pose no significant risk may be determined by the lead agency using an expedited method consistent with the procedures specified in Section 25703.
(1) Any interested party may request the lead agency to reevaluate a level established in this subsection and to consider the adoption, in subsection (c), of a level based on a state or federal risk assessment. Such request shall be made in writing, and shall include a copy of the state or federal risk assessment which the interested party wishes the lead agency to consider as the basis for a level in subsection (c). The lead agency may establish a level in subsection (c) for the chemical in question based on a state or federal risk assessment as it deems necessary.
(2) Any interested party may request the lead agency to reevaluate a level established in this subsection based on scientific considerations that indicate the need for a conventional risk assessment. Such request shall be made in writing, and shall include a description of the scientific considerations that indicate the need for a conventional risk assessment. The lead agency may conduct a conventional risk assessment for the chemical in question, and establish a level in subsection (b) as it deems necessary.
(3) The following levels of exposure based on risk assessments conducted by the lead agency using an expedited method consistent with the procedures specified in Section 25703 shall be deemed to pose no significant risk:
Chemical Name
Level (micrograms/day)
A-alpha-C
(2-Amino-9H-pyridol[2,3-b]indole)
2
Acetamide
10
2-Acetylaminofluorene
0.2
Actinomycin D
0.00008
AF-2;[2-(2-furyl)-3(5-nitro-2-furyl)
acrylamide]
3
2-Aminoanthraquinone
20
o-Aminoazotoluene
0.2
4-Aminobiphenyl (4-aminodiphenyl)
0.03
3-Amino-9-ethylcarbazole hydrochloride
9
l-Amino-2-methylanthraquinone
5
2-Amino-5-(5-nitro-2-furyl)
-1,3,4-thiadiazole
0.04
Amitrole
0.7
o-Anisidine
5
o-Anisidine hydrochloride
7
Aramite
20
Auramine
0.8
Azaserine
0.06
Azathioprine
0.4
Benzyl violet 4B
30
beta-Butyrolactone
0.7
Carbazole
4.1
Captafol
5
Captan
300
Chlorambucil
0.002
Chlordecone (Kepone)
0.04
Chlorendic acid
8
Chlorinated paraffins (Average chain
length, C12; approximately 60 percent
chlorine by weight)
8
Chloromethyl methyl ether
(technical grade)
0.3
3-Chloro-2-methylpropene
5
4-Chloro-ortho-phenylenediamine
40
p-Chloro-o-toluidine
3
p-Chloro-o-toluidine hydrochloride
3.3
Chlorozotocin
0.003
C. I. Basic Red 9 monohydrochloride
3
Cinnamyl anthranilate
200
p-Cresidine
5
Cupferron
3
Cyclophosphamide (anhydrous)
1
Cyclophosphamide (hydrated)
1
D&C Red No. 9
100
Dacarbazine
0.01
Daminozide
40
Dantron (Chrysazin;
1,8-Dihydroxyanthraquinone)
9
2,4-Diaminoanisole
30
2,4-Diaminoanisole sulfate
50
4,4'-Diaminodiphenyl ether
(4,4'-Oxydianiline)
5
2,4-Diaminotoluene
0.2
Dibenz[a,h]anthracene
0.2
1,1-Dichloroethane
100
Diethylstilbestrol
0.002
Digylcidyl resorcinol ether (DGRE)
0.4
Dihydrosafrole
20
4-Dimethylaminoazobenzene
0.2
trans-2[Dimethylamino)methylimino]-5-
[2-(5-nitro-2-furyl)vinyl]-
1,3,4-oxadiazole
2
7,12-Dimethylbenz(a)anthracene
0.003
Dimethylcarbamyl chloride
0.05
1,2-Dimethylhydrazine
0.001
Dimethylvinylchloride
20
Direct Black 38 (technical grade)
0.09
Direct Blue 6 (technical grade)
0.09
Direct Brown 95 (technical grade)
0.1
Disperse Blue 1
200
Estradiol 17B
0.02
Ethyl-4,4'-dichlorobenzilate
(chlorobenzilate)
7
Ethylene thiourea
20
Ethyleneimine
0.01
2-(2-Formylhydrazino)-4-(5-nitro-2-
furyl)thiazole
0.3
Glu-P-1 (2-Amino-6-methyldipyrido
[1,2-a:3',2'-d]imidazole
0.1
Glu-P-2 (2-Aminodipyrido[1,2-a:3',
2'-d]imidazole
0.5
Gyromitrin (Acetaldehyde
methylformylhydrazone)
0.07
HC Blue 1
10
Hexachloroethane
20
Hydrazobenzene (1,2-Diphenylhydrazine)
0.8
IQ (2-Amino-3-methylimidazo
[4,5-f]quinoline)
0.5
Isobutyl nitrite
7.4
Lasiocarpine
0.09
Me-A-alpha-C (2-Amino-3-
methyl-9H-pyrido[2,3-b]indole)
0.6
MeIQ (2-Amino-3,4-dimethylimidazo
0.46
[4,5-f]quinoline
MeIQx (2-Amino-3,8-dimethylimidazo
0.41
[4,5-f]quinoxaline
Melphalan
0.005
Methyl carbamate
160
3-Methylcholanthrene
0.03
4,4'-Methylene bis(2-chloroaniline)
0.5
4,4'-Methylene bis(2-methylaniline)
0.8
4,4'-Methylenedianiline
0.4
4,4'-Methylenedianiline dihydrochloride
0.6
Methyl methanesulfonate
7
2-Methyl-1-nitroanthraquinone
(of uncertain purity)
0.2
N-Methyl-N'-nitro-N-nitrosoguanidine
0.08
Methylthiouracil
2
Michler's ketone
0.8
Mirex
0.04
Mitomycin C
0.00009
Monocrotaline
0.07
Nalidixic acid
28
2-Naphthylamine
0.4
Nitrilotriacetic acid
100
Nitrilotriacetic acid, trisodium salt
monohydrate
70
5-Nitroacenaphthene
6
Nitrofen (technical grade)
9
Nitrofurazone
0.5
1-[(5-Nitrofurfurylidine)-amino]-
2-imidazolidinone
0.4
N-[4-(5-Nitro-2-furyl)-2-thiazolyl]
acetamide
0.5
p-Nitrodiphenylamine
30
4-(N-Nitrosomethylamino)-1-(3-pyridyl)-
0.014
1-butanone
N-Nitroso-N-methylurethane
0.006
N-Nitrosomorpholine
0.1
N-Nitrosonornicotine
0.5
N-Nitrosopiperidine
0.07
Phenacetin
300
Phenazopyridine
4
Phenazopyridine hydrochloride
5
Phenesterin
0.005
Phenobarbital
2
Phenoxybenzamine
0.2
Phenoxybenzamine hydrochloride
0.3
o-Phenylenediamine
26
o-Phenylenediamine dihydrochloride
44
o-Phenylphenate, sodium
200
Ponceau MX (D&C Red No. 5)
200
Ponceau 3R (FD&C Red No. 1)
40
Potassium bromate
1
Procarbazine
0.05
Procarbazine hydrochloride
0.06
1,3-Propane sultone
0.3
beta-Propiolactone
0.05
Propylthiouracil
0.7
Reserpine
0.06
Safrole
3
Sterigmatocystin
0.02
Streptozotocin
0.006
Styrene oxide
4
Sulfallate
4
1,1,2,2-Tetrachloroethane
3
Thioacetamide
0.1
4,4'-Thiodianiline
0.05
Thiourea
10
Toluene diisocyanate
20
o-Toluidine
4
o-Toluidine hydrochloride
5
Trimethyl phosphate
24
Tris(1-aziridinyl)phosphine
sulfide (Thiotepa)
0.06
Tris(2,3-dibromopropyl)phosphate
0.3
Trp-P-1 (Tryptophan-P-1)
0.03
Trp-P-2 (Tryptophan-P-2)
0.2
Vinyl trichloride (1,1,2-Trichloroethane)
10
Note: Authority cited: Section 25249.12, Health and Safety Code. Reference: Sections 25249.5, 25249.6, 25249.9, 25249.10, 25249.11 and 57004, Health and Safety Code.
HISTORY
1. New section filed 2-24-88 as an emergency; operative 2-27-88 (Register 88, No. 11). A Certificate of Compliance must be transmitted to OAL within 120 days or emergency language will be repealed on 6-27-88.
2. New section refiled 6-27-88 as an emergency; operative 6-27-88 (Register 88, No. 27). A Certificate of Compliance must be transmitted to OAL within 120 days or emergency language will be repealed on 10-25-88.
3. New section refiled 10-17-88 as an emergency; operative 10-25-88 (Register 88, No. 44). A Certificate of Compliance must be transmitted to OAL within 120 days or emergency language will be repealed on 2-22-89.
4. New section refiled 2-21-89 as an emergency; operative 2-22-89 (Register 89, No. 10). A Certificate of Compliance must be transmitted to OAL within 120 days or emergency language will be repealed on 6-22-89.
5. Certificate of Compliance including amendment transmitted to OAL 6-9-89 and filed 7-10-89 (Register 89, No. 30).
6. New subsection (b) filed 12-1-89; operative 12-31-89 (Register 89, No. 49).
7. Amendment of subsection (b) filed 5-16-90; operative 6-15-90 (Register 90, No. 25).
8. Amendment of subsection (b) filed 5-24-90; operative 6-23-90 (Register 90, No. 25).
9. Editorial correction of printing error in subsection (b) submitted to OAL for printing only 10-9-90 (Register 91, No. 3).
10. Amendment of subsection (b) adding Benzene filed 11-26-90; operative 12-26-90 (Register 91, No. 3).
11. Amendment of subsection (b) adding Arsenic, Butylated hydroxyanisole, Cadmium, and Chromium filed 9-16-92; operative 10-16-92 (Register 92, No. 38).
12. Amendment of subsection (b) adding Hexachlorodibenzodioxin and 2,3,7,8-Tetrachlorodibenzo-p-dioxin filed 9-16-92; operative 10-16-92 (Register 92, No. 38).
13. Amendment of subsection (b) adding dichloromethane, trichloroethylene and vinyl chloride filed 9-24-92; operative 10-26-92 (Register 92, No. 39).
14. Amendment of subsection (a), new subsections (b)-(b)(1), renumbering of subsection (c) to (b)(2) and amendment, new subsections (c)-(d)(3) filed 10-9-92; operative 11-9-92 (Register 92, No. 41).
15. Effective 10-29-99, allyl chloride and chlorodibromomethane were removed from the list of chemicals known to the State to cause cancer. The no significant risk levels of these chemicals were also removed, effective 10-29-99, from Title 22, CCR, sections 12705(c)(2) and 12705(d)(3) (Register 2001, No. 19).
16. Amendment of subsections (b), (c)(2) and (d)(3) filed 7-18-2002; operative 8-17-2002 (Register 2002, No. 29).
17. Amendment of subsections (a) and (b)(2) and deletion of extraneous subsection (b) designator filed 1-7-2003; operative 2-6-2003 (Register 2003, No. 2).
18. Amendment of subsections (b)(1) and (d)(3) filed 2-25-2003; operative 3-27-2003 (Register 2003, No. 9).
19. Amendment of subsection (b)(1) filed 4-12-2004; operative 5-12-2004 (Register 2004, No. 16).
20. Amendment of subsection (b)(1) filed 6-10-2004; operative 7-10-2004 (Register 2004, No. 24).
21. Amendment of subsection (b)(1) adding “1,2-Dichloropropane” filed 12-23-2004; operative 1-22-2005 (Register 2004, No. 52).
22. Amendment of subsections (b)(1) and (d)(3) filed 8-12-2005; operative 9-11-2005 (Register 2005, No. 32).
23. Change without regulatory effect amending subsection (d)(3) filed 1-30-2007 pursuant to section 100, title 1, California Code of Regulations (Register 2007, No. 5).
24. Effective December 8, 2006, 5 nitro-o-anisidine was removed from the list of chemicals known to cause cancer. This resulted in 5 nitro-o-anisidine and its no significant risk level contained in Section 12705(d)(3) no longer being applicable effective December 8, 2006. This change without regulatory effect removing 5 nitro-o-anisidine from Section 12705(d)(3) was filed 1-30-2007 pursuant to section 100, title 1, California Code of Regulations (Register 2007, No. 5).
25. Amendment of subsection (b)(1) adding “Nitromethane” filed 3-27-2008; operative 4-26-2008 (Register 2008, No. 13).
26. Change without regulatory effect renumbering title 22, section 12705 to title 27, section 25705, including amendment of subsections (b), (d) and (d)(3), filed 6-18-2008 pursuant to section 100, title 1, California Code of Regulations (Register 2008, No. 25).
27. Amendment of subsection (b)(1) filed 8-8-2008; operative 9-7-2008 (Register 2008, No. 32).
28. Amendment of subsection (b)(1) filed 4-7-2009; operative 5-7-2009 (Register 2009, No. 15).
29. Amendment of subsection (b)(1) filed 7-13-2010; operative 8-12-2010 (Register 2010, No. 29).
30. Amendment of subsection (b)(1) filed 1-26-2011; operative 2-25-2011 (Register 2011, No. 4).
31. Amendment of subsection (b)(1) filed 1-26-2011; operative 2-25-2011 (Register 2011, No. 4).
32. Amendment of subsection (b)(1) filed 1-9-2012; operative 2-8-2012 (Register 2012, No. 2).
33. Amendment of subsections (b)(1) and (d)(3) filed 3-15-2012; operative 6-15-2012 pursuant to Government Code section 11343.4(b) (Register 2012, No. 11).
34. Amendment of subsection (c)(2) filed 3-26-2012; operative 4-25-2012 (Register 2012, No. 13).
35. Amendment of subsection (b)(1) filed 6-18-2012; operative 7-18-2012 (Register 2012, No. 25).
36. Repealer of subsection (b)(2) and amendment of Note filed 7-12-2012; operative 8-11-2012 (Register 2012, No. 28).
37. Amendment of subsection (b)(1) adding Tris(1,3-dichloro-2-propyl) phosphate and amendment of Note filed 9-20-2012; operative 10-20-2012 (Register 2012, No. 38).
38. Editorial correction repealing subsection (b)(2) pursuant to 7-12-2012 filing (Register 2012, No. 39).
39. Amendment of subsection (b)(1) adding “Bromoethane” filed 12-17-2012; operative 1-16-2013 (Register 2012, No. 51).
40. Amendment of subsection (b)(1) adding “Diisononyl phthalate (DINP)” filed 2-8-2016; operative 4-1-2016 (Register 2016, No. 7).
41. Amendment of subsection (b)(1) adding “Styrene” filed 5-4-2017; operative 7-1-2017 (Register 2017, No. 18).
42. Amendment of subsection (b)(1) adding “Malathion” filed 2-5-2018; operative 4-1-2018 (Register 2018, No. 6).
43. Amendment of subsection (b)(1) adding “Glyphosate” filed 4-6-2018; operative 7-1-2018 (Register 2018, No. 14).
44. Amendment of subsection (b)(1) adding “Vinylidene chloride” filed 5-9-2018; operative 7-1-2018 (Register 2018, No. 19).
45. Amendment of subsection (b)(1) adding “Bromochloroacetic acid” filed 2-5-2019; operative 4-1-2019 (Register 2019, No. 6).
46. Amendment of subsection (b)(1) adding “Bromodichloroacetic acid” filed 2-5-2019; operative 4-1-2019 (Register 2019, No. 6).
This database is current through 10/16/20 Register 2020, No. 42
27 CCR § 25705, 27 CA ADC § 25705
End of Document© 2020 Thomson Reuters. No claim to original U.S. Government Works.